DONG Qian, TIAN Meng, MU Ruihong. Research on Supervision System of Combination Product in FDA[J]. Chinese Journal of Medical Instrumentation, 2021, 45(6): 670-673. DOI: 10.3969/j.issn.1671-7104.2021.06.016
Citation:
DONG Qian, TIAN Meng, MU Ruihong. Research on Supervision System of Combination Product in FDA[J]. Chinese Journal of Medical Instrumentation, 2021, 45(6): 670-673. DOI: 10.3969/j.issn.1671-7104.2021.06.016
DONG Qian, TIAN Meng, MU Ruihong. Research on Supervision System of Combination Product in FDA[J]. Chinese Journal of Medical Instrumentation, 2021, 45(6): 670-673. DOI: 10.3969/j.issn.1671-7104.2021.06.016
Citation:
DONG Qian, TIAN Meng, MU Ruihong. Research on Supervision System of Combination Product in FDA[J]. Chinese Journal of Medical Instrumentation, 2021, 45(6): 670-673. DOI: 10.3969/j.issn.1671-7104.2021.06.016
Research on Supervision System of Combination Product in FDA
On the basis of introducing FDA’s regulatory measure and relevant requirement for life-cycle management of combination product, this paper aims to discuss corresponding countermeasure for supervision system construction in consideration of domestic drug-device combination product’s current situation, in order to promote innovative development of relevant industries.
DownLoad: